Kyowa Hakko Kirin

Results: 49



#Item
11

April 24, 2014 Kyowa Hakko Kirin Co., Ltd. Appendix to the Consolidated Financial Summary Fiscal 2014 First Quarter

Add to Reading List

Source URL: www.kyowa-kirin.com

Language: English - Date: 2014-04-24 00:40:12
    12

    FOR IMMEDIATE RELEASE August 6, 2014 Listed Company Name: Kyowa Hakko Kirin Co., Ltd. Representative: Nobuo Hanai, President and CEO (Code no.: 4151, First Section of Tokyo) Inquiries: Shigeru Morotomi, Executive Officer

    Add to Reading List

    Source URL: www.kyowa-kirin.com

    - Date: 2014-08-05 20:10:04
      13

      April 28, 2015 Kyowa Hakko Kirin Co., Ltd. Appendix to the Consolidated Financial Summary Fiscal 2015 First Quarter

      Add to Reading List

      Source URL: www.kyowa-kirin.com

      Language: English - Date: 2015-04-28 00:40:09
        14

        FOR IMMEDIATE RELEASE July 11, 2014 Listed Company Name: Kyowa Hakko Kirin Co., Ltd. Representative: Nobuo Hanai, President and CEO (Code no.: 4151, First Section of TSE)

        Add to Reading List

        Source URL: www.kyowa-kirin.com

        Language: English - Date: 2014-07-11 03:10:04
          15

          Fiscal 2013 Results Presentation (Fiscal year to December 31, 2013) February 3, 2014 Kyowa Hakko Kirin Co., Ltd.

          Add to Reading List

          Source URL: www.kyowa-kirin.com

          Language: English - Date: 2014-02-07 03:00:16
            16

            Kyowa Hakko Kirin and Bristol-Myers Squibb Announce Immuno-Oncology Clinical Collaboration Studying Mogamulizumab and Opdivo (nivolumab) in Advanced Solid Tumors in the U.S. (NEW YORK and TOKYO, July 29, Kyowa Ha

            Add to Reading List

            Source URL: www.kyowa-kirin.com

            Language: English - Date: 2015-07-29 19:00:03
              17

              January 31, 2014 Kyowa Hakko Kirin Co., Ltd. Appendix to the Fiscal 2013 Consolidated Financial Statements

              Add to Reading List

              Source URL: www.kyowa-kirin.com

              Language: English - Date: 2014-01-30 23:55:16
                18

                FOR IMMEDIATE RELEASE March 31, 2015 Listed Company Name: Kyowa Hakko Kirin Co., Ltd. Representative: Nobuo Hanai, President and CEO (Code no.: 4151, First Section of TSE) Inquiries: Shigeru Morotomi, Executive Officer

                Add to Reading List

                Source URL: www.kyowa-kirin.com

                Language: English - Date: 2015-03-30 20:10:04
                  19

                  FOR IMMEDIATE RELEASE March 28, 2014 Listed Company Name: Kyowa Hakko Kirin Co., Ltd. Representative: Nobuo Hanai, President and CEO (Code no.: 4151, First Section of TSE) Inquiries: Shigeru Morotomi, Executive Officer

                  Add to Reading List

                  Source URL: www.kyowa-kirin.com

                  Language: English - Date: 2014-03-28 02:40:04
                    20

                    ONO PHARMACEUTICAL CO., LTD. Bristol-Myers Squibb Company Kyowa Hakko Kirin Co., Ltd. ONO PHARMACEUTICAL, Bristol-Myers Squibb and Kyowa Hakko Kirin Announce Immuno-Oncology Clinical Collaboration Studying Opdivo (nivolu

                    Add to Reading List

                    Source URL: www.kyowa-kirin.com

                    Language: English - Date: 2014-12-10 01:00:04
                      UPDATE